Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Legal Name: SOFINNOVA INVESTMENTS, INC.
Berichtszeitraum:
Jun 30, 2019
Gültigkeitsdatum:
Aug 13, 2019
| Sicherheit |
Gehaltene Aktien / Nennbetrag |
Marktwert |
Möglichkeit |
|
ASCENDIS PHARMA A S (04351P101)
|
1,099,824 |
$126,645k |
|
|
B. Riley Wealth Management, Inc. (023111206)
|
5,208,305 |
$100,989k |
|
|
NATERA INC (632307104)
|
3,100,560 |
$85,513k |
|
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
2,038,208 |
$67,648k |
|
|
OBSEVA SA (H5861P103)
|
4,749,623 |
$53,718k |
|
|
SPARK THERAPEUTICS INC (84652J103)
|
481,270 |
$49,272k |
|
|
Y-MABS THERAPEUTICS INC (984241109)
|
2,104,278 |
$48,125k |
|
|
COHERUS BIOSCIENCES INC (19249H103)
|
2,093,221 |
$46,260k |
|
|
NEXTCURE INC (65343E108)
|
2,521,856 |
$37,777k |
|
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
933,640 |
$35,348k |
|
|
KARUNA THERAPEUTICS INC (48576A100)
|
1,729,352 |
$34,622k |
|
|
MERUS N V (N5749R100)
|
1,961,039 |
$28,729k |
|
|
Nucana Biomed Ltd (GB00BYWYV)
|
2,400,000 |
$24,912k |
|
|
Nucana Biomed Ltd (67022C106)
|
2,266,666 |
$23,528k |
|
|
KINISKA PHARMACEUTIC (G5269C101)
|
922,700 |
$12,493k |
|
|
CHIASMA INC (16706W102)
|
1,630,221 |
$12,178k |
|
|
ITERUM THERAPEUTICS (G6333L101)
|
1,726,514 |
$11,878k |
|
|
ENTASIS THERAPEUTICS HOLDING (293614103)
|
1,180,178 |
$7,612k |
|
|
NOVO-NORDISK AS (670100205)
|
138,371 |
$7,062k |
|
|
PTC THERAPEUTICS INC (69366J200)
|
156,727 |
$7,053k |
|
|
ALLERGAN PLC (G0177J108)
|
35,876 |
$6,007k |
|
|
Neurocrine Biosciences Inc. (64125C109)
|
66,638 |
$5,626k |
|
|
SYNLOGIC INC (87166L100)
|
574,972 |
$5,232k |
|
|
HALOZYME THERAPEUTICS INC (40637H109)
|
298,345 |
$5,126k |
|
|
HERON THERAPEUTICS INC (427746102)
|
262,438 |
$4,879k |
|
|
TG THERAPEUTICS INC (88322Q108)
|
537,747 |
$4,652k |
|
|
Reata Pharmaceuticals Inc. (75615P103)
|
49,067 |
$4,629k |
|
|
Acceleron Pharma Inc (00434H108)
|
102,383 |
$4,206k |
|
|
ACLARIS THERAPEUTICS INC (00461U105)
|
1,911,573 |
$4,186k |
|
|
Vertex Pharmaceuticals Inc (92532F100)
|
21,756 |
$3,990k |
|
|
MACROGENICS INC (556099109)
|
234,661 |
$3,982k |
|
|
AMGEN INC (031162950)
|
21,400 |
$3,944k |
Put |
|
MorphoSys AG (D55040105)
|
41,061 |
$3,943k |
|
|
Allergan plc (G0177J908)
|
21,300 |
$3,566k |
Call |
|
Bristol-Myers Squibb Co (110122108)
|
74,368 |
$3,373k |
|
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
36,752 |
$3,148k |
|
|
DERMIRA INC (24983L104)
|
282,180 |
$2,698k |
|
|
Incyte Corp (45337C102)
|
29,736 |
$2,526k |
|
|
AMICUS THERAPEUTICS INC (03152W109)
|
195,220 |
$2,436k |
|
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
157,799 |
$2,208k |
|
|
KADMON HOLDINGS INC (48283N106)
|
957,858 |
$1,973k |
|
|
BRISTOL MYERS SQUIBB CO (110122908)
|
42,700 |
$1,936k |
Call |
|
ACADIA PHARMACEUTCLS (004225108)
|
66,504 |
$1,778k |
|
|
ZYMEWORKS INC (98985W102)
|
80,417 |
$1,769k |
|
|
AKEBIA THERAPEUTICS INC (00972D105)
|
362,177 |
$1,753k |
|
|
UNIQURE N.V. (N90064101)
|
21,300 |
$1,665k |
Call |
|
OTONOMY INC (68906L105)
|
585,775 |
$1,611k |
|
|
ARQULE INC (04269E107)
|
120,403 |
$1,326k |
|
|
APELLIS PHARMACEUTICALS INC (03753U106)
|
49,580 |
$1,256k |
|
|
FOAMIX PHARMACUTICLS (M46135105)
|
476,173 |
$1,133k |
|
|
Xbiotech Inc (98400H102)
|
141,839 |
$1,075k |
|
|
Zogenix Inc (98978L904)
|
21,200 |
$1,013k |
Call |
|
Deciphera Pharmaceuticals Inc (24344T951)
|
42,800 |
$965k |
Put |
|
SYNDAX PHARMACEUTICALS INC (87164F105)
|
103,679 |
$965k |
|
|
Intra-Cellular Therapies Inc (46116X901)
|
74,300 |
$964k |
Call |
|
ADVERUM BIOTECHNOLOGIES INC (00773U108)
|
79,453 |
$945k |
|
|
ABBVIE INC (00287Y109)
|
12,391 |
$901k |
|
|
CALITHERA BIOSCIENCES INC (13089P101)
|
226,756 |
$884k |
|
|
OSMOTICA PHARMACEUTICALS PLC (G6S41R101)
|
227,022 |
$863k |
|
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
11,846 |
$860k |
|
|
PDS Biotechnology Corporation (70465T107)
|
142,635 |
$854k |
|
|
Kala Pharmaceuticals, Inc. (483119103)
|
128,557 |
$820k |
|
|
CLOVIS ONCOLOGY INC COM (189464100)
|
53,576 |
$797k |
|
|
INTRA-CELLULAR THERAPIES INC (46116X101)
|
53,694 |
$697k |
|
|
BIOCRYST PHARMACEUTICALS (09058v103)
|
181,159 |
$687k |
|
|
ACORDA THERAPEUTICS INC COM (00484M106)
|
82,431 |
$632k |
|
|
FORTY SEVEN INC (34983P104)
|
50,774 |
$538k |
|
|
APPLIED THERAPEUTICS INC (03828A101)
|
61,330 |
$505k |
|
|
AUTOLUS THERAPEUTICS PLC (05280R100)
|
28,060 |
$452k |
|
Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.
Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.
Kürzlich gesuchte Firmen
Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.